Right to FDA-Approved Medicines Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 17, 2025)
Right to FDA-Approved Medicines Act
This bill sets out statutory protections for an individual's right to access and a health care provider's right to provide medicines (i.e., drugs and biological products) approved by the Food and Drug Administration (FDA).
Generally, the bill prohibits measures that single out and impede access to FDA-approved medicines and related information. However, a party may defend against a claim that a measure violates the bill's prohibitions by demonstrating, through clear and convincing evidence, that the measure significantly advances access to FDA-approved medicines and such access cannot be advanced through less restrictive means. The bill also specifies that the prohibition preempts inconsistent state and local laws and applies in spite of other federal laws, including the Religious Freedom Restoration Act of 1993.
The Department of Justice, individuals, or health care providers may bring a lawsuit to enforce this bill, and states are not immune from suits for violations.
What just happenedJul 17, 2025
Referred to the House Committee on Energy and Commerce.
Who’s behind it
- Introduced in HouseJul 17, 2025
- Jul 17, 2025IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jul 17, 2025IntroReferralIntro-H
Introduced in House
- Jul 17, 2025IntroReferral1000
Introduced in House